Dan Spakowicz, PhD
The Ohio State University
Research Project:
Adenosine as a Mediator of Tumor and Tumor-Microbiome Interactions in Non-small Cell Lung Cancer
Grant Awarded:
- Innovation Award
Research Topics:
- basic biologic mechanisms
- clinical research
- combination therapies experimental therapeutics
- computational biology
- immunology immunotherapy
- risk factors
Research Disease:
- lung cancer
Lung cancer treatment with drugs called immune checkpoint inhibitors has been effective for some patients, but over half of the treated tumors do not respond. Combination therapies, including blocking tumor signaling pathways that suppress the immune system, are a promising approach to improving outcomes. A cell chemical called adenosine enables tumor cells to escape immune surveillance. However, our and others’ recent findings suggest that the microbiome (the collection of bacteria, viruses, and fungi that live on and inside the human body) may act on adenosine’s cell signaling pathway to support or impair immune system function, depending on where the chemical is produced. We need more information about how gut and lung tumor microbiomes affect the emerging combination therapies that target adenosine signaling and immune checkpoints. Our research will provide insight into this process and may lead to improved treatment for patients with lung cancer.
Update:
In our first year, we assembled the largest lung tumor microbiome dataset to date to explore how microbes relate to key regulatory pathways and treatment outcomes. These analyses required that we create several tools, which are now publicly available. To define causal relationships, we’ll perform mouse experiments where we can control the microbes in the gut and tumors and measure their effects on treatment responses. We hope this work will lead to microbe-related interventions (e.g., probiotics) that can be used with some lung cancers to improve treatment responses and patient outcomes.
Page last updated: September 17, 2024
Double Your Support Now
Your gift will have 2X the impact this COPD Awareness Month.
